Chinese Vaccine Providers’ Perspectives on the HPV Vaccine

China approved a human papillomavirus (HPV) vaccine in 2018. Recommendations from health care providers can positively impact vaccine receipt. This study characterized vaccine providers’ attitudes toward the HPV vaccine and contrasted attitudes by the providers’ demographic characteristics. In total...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Mengdi, Huang, Zhuoying, Ren, Jia, Sun, Xiaodong, Wagner, Abram L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Section: Infectious Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7597565/
https://www.ncbi.nlm.nih.gov/pubmed/33195744
http://dx.doi.org/10.1177/2333794X20967592

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7597565/
https://www.ncbi.nlm.nih.gov/pubmed/33195744
http://dx.doi.org/10.1177/2333794X20967592

Ejemplares similares